Seattle breakthrough offers Spokane boy relief from rare hunger condition
The FDA has authorized a new therapy to treat hypothalamic obesity resulting from brain injuries and tumors.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The FDA has granted approval for the use of setmelanotide as a treatment for hypothalamic obesity, a condition stemming from brain injuries or tumors that results in persistent hunger. A trial conducted at Seattle Children’s documented the intervention's application for a patient from Spokane.
Coverage from outlets including The Spokesman-Review, KREM, and The ASCO Post highlights clinical trial results showing reductions in Body Mass Index (BMI). Additional reporting from Northwestern University and the NR Times emphasizes the physiological focus of the therapy on hypothalamic function.
Future developments hinge on the broader clinical rollout of setmelanotide following this regulatory authorization. Further reporting is expected to address the therapy's long-term effectiveness in patients with acquired hypothalamic obesity.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 3h ago.
Quick answers
What is the new therapy approved by the FDA?
The FDA approved setmelanotide for the treatment of hypothalamic obesity caused by brain injuries or tumors.
What condition does this therapy treat?
It targets hypothalamic obesity, a rare condition that causes constant hunger in patients with brain damage or tumors.
Where were the clinical trials conducted?
Trials included work conducted at Seattle Children’s.
Coverage (7)
- FDA approves new therapy for obesity caused by brain injury NR Times · 1d ago
- Setmelanotide cuts BMI in hypothalamic obesity trial the limbic · 1d ago
- Seattle Children’s trial helps Spokane boy with rare obesity disorder tied to brain injury MSN · 1d ago
- Setmelanotide in Patients With Acquired Hypothalamic Obesity From Brain Tumors The ASCO Post · 1d ago
- ‘Back to living life’: Spokane boy finds treatment to constant hunger caused by brain damage The Spokesman-Review · 1d ago
- Treating a Rare Form of Obesity Caused by Brain Injury Northwestern University · 1d ago
- Seattle breakthrough offers Spokane boy relief from rare hunger condition KREM · 1d ago
Topics
Related trends
FDA still focused on Taylor Farms lettuce as Cyclospora source despite retracted test
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Douglas County officials: 'Rapid' Cyclospora surge reported, Taco Bell emerges as top exposure
A rapid surge in Cyclospora infections is prompting investigations into iceberg lettuce, with Taco Bell cited as a primary point of exposure.
FDA retracts test result but still links Taylor Farms lettuce to cyclosporiasis
Federal health officials maintain a focus on Taylor Farms lettuce in a cyclosporiasis investigation despite retracting a specific test result.
FDA Walks Back Finding of Cyclospora Parasite as Outbreak Probe Continues
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
FDA says Taylor Farms cyclospora finding was a false positive
16 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Too many Britons are too fat to work
A new study says obesity may be keeping over 600,000 Britons out of work.